Adoptive Cell Therapy Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type
This report describes the global market size of Adoptive Cell Therapy from 2020 to 2024 and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030.
For geography segment, regional supply, demand, major players, price is presented from 2020 to 2030. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Adoptive Cell Therapy as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
Types Segment:
Tumor-Infiltrating Lymphocyte (TIL) Therapy
Engineered T Cell Receptor (TCR) Therapy
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Companies Covered:
Iovance Biotherapeutics Inc.
Adaptimmune Therapeutics Plc.
Achilles Therapeutics Ltd.
Intima Bioscience Inc.
Nurix Therapeutics Inc.
KSQ Therapeutics Inc.
Obsidian Therapeutics Inc.
PACT Pharma Inc.
Neogene Therapeutics
Instil Bio Inc.
Kite Pharma Inc./Gilead
Juno Therapeutics Inc./Bristol-Myers Squibb
TCR2 Therapeutics Inc.
Poseida Therapeutics Inc.
Immatics N.V.
etc.
Please ask for sample pages for full companies list
Base Year: 2025
Historical Data: from 2020 to 2024
Forecast Data: from 2025 to 2030